Hemolysis index. Can we uncritically trust manufacturer declarations?
Manufacturer instructions often lack completeness and consistency, making it crucial for clinical laboratories to independently validate hemolysis thresholds. A harmonized approach, incorporating manufacturer data, research, and local validation, is essential to improve laboratory quality, minimize misinterpretations, and ensure compliance with regulatory standards.
Authors
- Marijana Miler (ORCID: https://orcid.org/0000-0002-0569-924X)
- Petra Filipi
- Marina Bocan
- Valentina Vidranski
- Ivana Ćelap (ORCID: https://orcid.org/0000-0002-3982-5777)
- Alen Vrtarić (ORCID: https://orcid.org/0000-0002-4104-1402)
- Nora Nikolac (ORCID: https://orcid.org/0000-0001-6831-6309)
- Marija Kocijančić (ORCID: https://orcid.org/0000-0003-1502-5705)
Institutions
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
- Polyclinic Medical Center (US)
- University Children's Hospital Tübingen (DE)
- Croatian Science Foundation (HR)
- University of Tübingen (DE)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1515/cclm-2025-1302
- Primary Topic
- Clinical Laboratory Practices and Quality Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00